Matthew McRae sold 1.59M ARLO shares earlier raising $27.13M
Rhea-AI Filing Summary
Arlo Technologies, Inc. (ARLO) Form 144 notifies a proposed sale of 520,557 common shares acquired as performance stock units on 08/08/2025. The shares are listed for sale through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $9,055,765.74 and the issuer's outstanding shares listed as 104,370,654.
The filing also records prior open-market sales by Matthew Blake McRae totaling 1,594,479 shares in the past three months, producing gross proceeds of $27,134,796.12. The filer certifies no knowledge of undisclosed material adverse information and references trading-plan disclosure language in the remarks.
Positive
- None.
Negative
- Recent insider dispositions: The filer sold 1,594,479 shares in the past three months, generating $27,134,796.12 in gross proceeds.
- Proposed sale size: The Form 144 notifies an additional intended sale of 520,557 shares valued at $9,055,765.74.
Insights
TL;DR: Insider proposes to sell 520,557 ARLO shares; recent sales totaled 1.59M shares for $27.13M.
The Form 144 reports a planned disposition of 520,557 common shares acquired as performance stock units on 08/08/2025, valued at about $9.06M. Recent open-market disposals by the same account total 1,594,479 shares for approximately $27.13M in gross proceeds during the prior three months. Those amounts represent roughly 1.53% of the company's outstanding shares sold earlier and an additional ~0.50% proposed here, based on the reported 104,370,654 shares outstanding. The filing is routine disclosure of intended insider selling without additional financial detail.
TL;DR: Filing documents substantial insider sales and affirms the filer’s representation about material nonpublic information.
The notice confirms the securities to be sold were received as compensation (performance stock units) and that sales will be executed via Morgan Stanley Smith Barney on the NYSE. The remarks include the standard certification that the seller is unaware of undisclosed material adverse information and reference to trading-plan language. The document is a compliance disclosure that provides transparency about insider dispositions but does not include commentary on company operations or intent beyond the statutory representations.